|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1990-10-19
|
|
pubmed:abstractText |
An 8-week double-blind study was carried out in 177 ragweed patients with seasonal allergic rhinitis to compare nedocromil sodium 1% nasal solution (Tilarin, QID, Fisons plc) and placebo. Symptoms of rhinitis were significantly reduced by nedocromil sodium during the peak 3-week pollen season (P = .001 for diary summary score) and the active treatment was rated effective by 74% of patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0003-4738
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
212-6
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2169714-Administration, Inhalation,
pubmed-meshheading:2169714-Adolescent,
pubmed-meshheading:2169714-Adult,
pubmed-meshheading:2169714-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:2169714-Child,
pubmed-meshheading:2169714-Double-Blind Method,
pubmed-meshheading:2169714-Humans,
pubmed-meshheading:2169714-Middle Aged,
pubmed-meshheading:2169714-Multicenter Studies as Topic,
pubmed-meshheading:2169714-Nedocromil,
pubmed-meshheading:2169714-Placebos,
pubmed-meshheading:2169714-Pollen,
pubmed-meshheading:2169714-Quinolones,
pubmed-meshheading:2169714-Rhinitis, Allergic, Seasonal,
pubmed-meshheading:2169714-Solutions
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis.
|
|
pubmed:affiliation |
Division of Allergy and Immunology, St. Louis University Medical School, MO.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Controlled Clinical Trial,
Multicenter Study
|
